Literature DB >> 26342592

Correlation between FDG-PET/CT findings and solid type non-small cell cancer prognostic factors: are there differences between adenocarcinoma and squamous cell carcinoma?

Rintaro Ito1, Shingo Iwano2, Mariko Kishimoto1, Shinji Ito1, Katsuhiko Kato3, Shinji Naganawa1.   

Abstract

OBJECTIVES: The maximum standardized uptake value (SUVmax) of FDG-PET/CT is commonly used as an indicator to evaluate the invasiveness and prognosis of non-small-cell lung cancers (NSCLC). We investigated the correlation between SUVmax and tumor invasiveness or postoperative recurrence of solid type NSCLC and compared squamous cell carcinoma (SCC)/adenosquamous carcinoma (ASC) to adenocarcinoma (AC).
METHODS: A retrospective review of preoperative PET/CT, thin-section CT, and postoperative pathological records obtained over a 5-year period was conducted. Solid type NSCLC tumors on thin-section CT with confirmed diagnosis from surgical resection (diameter ≤3 cm) were included. Multivariate logistic regression was used to evaluate the correlation between tumor characteristics and pathological prognostic factors or postoperative recurrence.
RESULTS: 150 patients (111 males, 39 females; mean age 67 years; 106 cases of AC, 36 cases of SCC, and 8 cases of ASC) were included. SUVmax was significantly correlated with pleural involvement (p = 0.047), lymphatic permeation (p = 0.003), lymph node metastasis (p = 0.027), and tumor invasiveness (p < 0.001). Receiver operating characteristic analysis indicated an optimal SUVmax threshold of 5.0 for tumor invasiveness. Histopathological type was significantly correlated with pleural involvement (p = 0.042), but not with other types of invasiveness. Twenty-nine patients experienced postoperative recurrence. SUVmax was significantly correlated with tumor recurrence (p = 0.004), but size and histopathological type were not (p = 0.502 and p = 0.351, respectively).
CONCLUSION: SUVmax of the primary lesion in solid type NSCLC was significantly correlated with tumor invasiveness and postoperative recurrence. No differences in tumor invasiveness were observed between solid type AC and SCC/ASC. However, in solid type AC, SUVmax of the primary lesion was more significantly correlated with recurrence.

Entities:  

Keywords:  Adenocarcinoma; Adenosquamous carcinoma; Non-small-cell lung cancer; Positron emission tomography; Squamous cell carcinoma

Mesh:

Substances:

Year:  2015        PMID: 26342592     DOI: 10.1007/s12149-015-1025-z

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  8 in total

1.  18F-FDG PET/CT and circulating tumor cells in treatment-naive patients with non-small-cell lung cancer.

Authors:  Fengxian Zhang; Xiaodong Wu; Junjie Zhu; Yan Huang; Xiao Song; Lei Jiang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-02-25       Impact factor: 9.236

2.  Comparison of cytology, chest computed and positron emission tomography findings in malignant pleural effusion from lung cancer.

Authors:  Clement Brun; Pierre Gay; Michele Cottier; Georgia Karpathiou; Arnaud Patoir; Oliviet Tiffet; Fabrice-Guy Barral; Jean-Michel Vergnon; Marios E Froudarakis
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

3.  Morphologic and Metabolic Comparison of Treatment Responsiveness with 18Fludeoxyglucose-Positron Emission Tomography/Computed Tomography According to Lung Cancer Type.

Authors:  Mehmet Fatih Börksüz; Taner Erselcan; Zekiye Hasbek; Birsen Yücel; Bülent Turgut
Journal:  Mol Imaging Radionucl Ther       Date:  2016-06-05

Review 4.  The Role of PET/CT Molecular Imaging in the Diagnosis of Recurrence and Surveillance of Patients Treated for Non-Small Cell Lung Cancer.

Authors:  Julio Francisco Jiménez-Bonilla; Remedios Quirce; I Martínez-Rodríguez; María De Arcocha-Torres; José Manuel Carril; Ignacio Banzo
Journal:  Diagnostics (Basel)       Date:  2016-09-30

5.  Postoperative recurrence of clinical early-stage non-small cell lung cancers: a comparison between solid and subsolid nodules.

Authors:  Shingo Iwano; Hiroyasu Umakoshi; Shinichiro Kamiya; Kohei Yokoi; Koji Kawaguchi; Takayuki Fukui; Shinji Naganawa
Journal:  Cancer Imaging       Date:  2019-06-07       Impact factor: 3.909

6.  Fluorine-18-fluorodeoxyglucose-positron emission tomography evaluation in metastatic bone lesions in lung cancer: Possible prediction of pain and skeletal-related events.

Authors:  Daisuke Gomi; Toshirou Fukushima; Takashi Kobayashi; Nodoka Sekiguchi; Tomonobu Koizumi; Kazuhiko Oguchi
Journal:  Thorac Cancer       Date:  2019-03-18       Impact factor: 3.500

7.  Evaluation of locoregional invasiveness of small-sized non-small cell lung cancers by enhanced dual-energy computed tomography.

Authors:  Hironori Shimamoto; Shingo Iwano; Hiroyasu Umakoshi; Koji Kawaguchi; Shinji Naganawa
Journal:  Cancer Imaging       Date:  2016-07-26       Impact factor: 3.909

8.  Preoperative identification of clinicopathological prognostic factors for relapse-free survival in clinical N1 non-small cell lung cancer: a retrospective single center-based study.

Authors:  Masato Aragaki; Tatsuya Kato; Aki Fujiwara-Kuroda; Yasuhiro Hida; Kichizo Kaga; Satoru Wakasa
Journal:  J Cardiothorac Surg       Date:  2020-08-28       Impact factor: 1.637

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.